NEW YORK – Bionano Genomics on Wednesday priced a $200 million underwritten public offering of its common stock that it announced the previous day.
The company plans to sell 33,333,350 shares of its common stock at a price of $6 per share, for an expected $200 million in gross proceeds. In addition, the underwriters have a 30-day option to purchase up to another 5,000,002 shares of common stock at the public offering price. The offering is expected to close on Jan. 22, subject to customary closing conditions.
